One dose of AstraZeneca’s monoclonal antibody cocktail protects against COVID-19 for six months or longer.
Omicron variant
Posted inClinical Trials, COVID-19, Infections
Upamostat: Oral Medication for COVID-19
Upamostat by RedHill Biopharma prevents COVID-19 complications from developing followed by hospitalization or death.
Posted inClinical Trials, COVID-19, Infections, Oncology
Yeliva: New Drug for COVID-19
Oral opaganib will reduce the likelihood of death and accelerate recovery in hospitalized patients with COVID-19.
Posted inClinical Trials, COVID-19, Infections
MesenCure: Israeli Miracle Drug Saves From Death by COVID-19
A cell therapy developed by Bonus BioGroup is amazingly able to fight coronavirus and its most severe complications.
Posted inCOVID-19, Infections, Research
Paxlovid Works Against Omicron
The newest COVID-19 treatment is highly effective against the Omicron variant of SARS-CoV-2 coronavirus.
Posted inClinical Trials, COVID-19, Infections
Adintrevimab: Cure for All Mutant Variants of SARS-CoV-2
Adagio Therapeutics’ monoclonal antibody will help fight all variants of the coronavirus.
Posted inClinical Trials, COVID-19, Infections
Ensovibep: Drug for All Variants of Coronavirus Including Omicron
Molecular Partners and Novartis believe in the success of DARPins.